Skip to main content
Top
Published in: Supportive Care in Cancer 4/2024

Open Access 01-04-2024 | Acupuncture | Review

Acupuncture in cancer care: recommendations for safe practice (peer-reviewed expert opinion)

Authors: Beverley de Valois, Teresa Young, Catherine Zollman, Ian Appleyard, Eran Ben-Arye, Mike Cummings, Ruth Green, Caroline Hoffman, Judith Lacey, Felicity Moir, Rachel Peckham, Jacqui Stringer, Susan Veleber, Matthew Weitzman, Kathrin Wode

Published in: Supportive Care in Cancer | Issue 4/2024

Login to get access

Abstract

Background

Up-to-date recommendations for the safe practice of acupuncture in integrative oncology are overdue with new cancer treatments and an increase in survivors with late effects of disease; 17 years have elapsed since Filshie and Hester’s 2006 guidelines. During 2022/2023 an expert panel assembled to produce updated recommendations aiming to facilitate safe and appropriate care by acupuncturists working with people with cancer.

Methods

A core development team comprising three integrative oncology professionals comprehensively updated pre-existing unpublished recommendations. Twelve invited international experts (senior acupuncturists with and without experience of working in oncology settings, oncologists, physicians and nurses trained in integrative oncology, researchers, academics, and professional body representatives) reviewed the recommendations. In multiple iterations, the core team harmonised comments for final ratification. To aid dissemination and uptake the panel represents national and international integrative oncology associations and major cancer treatment centres in Europe, USA, Australia, and the Middle East.

Results

These recommendations facilitate safe care by articulating contra-indications, cautions, and risks for patients both on and off treatment (surgery, SACT, radiotherapy). Situations where acupuncture may be contra-indicated or practices need adapting are identified. “Red and Amber Flags” highlight where urgent referral is essential.

Conclusion

These are the first international, multidisciplinary peer-reviewed recommendations for safe acupuncture practice in integrative oncology. Concerns about safety remain a significant barrier to appropriate referral from oncology teams, to use by acupuncturists and to uptake by patients. Disseminating trustworthy, widely accessible guidance should facilitate informed, confident practice of acupuncture in and outside of oncology healthcare settings.
Literature
7.
go back to reference Mao JJ, Nofisat I, Ting B, Debra B, Eran B-A, Eric LG, Heather G, Thomas L, Richard TL, Ana Maria L, Charles L, Gary HL, Jodi M, Viraj AM, Kavitha R, Lynne IW, Eleanor MW, Deborah Watkins B, Claudia MW, Eduardo B (2022) Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline. J Clin Oncol 40:3998–4024CrossRefPubMed Mao JJ, Nofisat I, Ting B, Debra B, Eran B-A, Eric LG, Heather G, Thomas L, Richard TL, Ana Maria L, Charles L, Gary HL, Jodi M, Viraj AM, Kavitha R, Lynne IW, Eleanor MW, Deborah Watkins B, Claudia MW, Eduardo B (2022) Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline. J Clin Oncol 40:3998–4024CrossRefPubMed
9.
go back to reference Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):85–120PubMed Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):85–120PubMed
10.
go back to reference Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH (2023) Integrative oncology care of symptoms of anxiety and depression in adults with cancer: Society for integrative oncology-ASCO guideline. J Clin Oncol 41(28):4562–4591. https://doi.org/10.1200/JCO.23.00857CrossRefPubMed Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH (2023) Integrative oncology care of symptoms of anxiety and depression in adults with cancer: Society for integrative oncology-ASCO guideline. J Clin Oncol 41(28):4562–4591. https://​doi.​org/​10.​1200/​JCO.​23.​00857CrossRefPubMed
13.
go back to reference Price S, Long AF, Godfrey M (2013) Exploring the needs and concerns of women with early breast cancer during chemotherapy: valued outcomes during a course of traditional acupuncture Evid Based Complement Alternat Med. 2013165891. https://doi.org/10.1155/2013/165891 Price S, Long AF, Godfrey M (2013) Exploring the needs and concerns of women with early breast cancer during chemotherapy: valued outcomes during a course of traditional acupuncture Evid Based Complement Alternat Med. 2013165891. https://​doi.​org/​10.​1155/​2013/​165891
14.
go back to reference de Valois B (2023) Supporting resilience and the immune system. In: Acupuncture and cancer survivorship: Recovery, renewal and transformation. Singing Dragon, London. de Valois B (2023) Supporting resilience and the immune system. In: Acupuncture and cancer survivorship: Recovery, renewal and transformation. Singing Dragon, London.
20.
30.
go back to reference Polomano R, Ashburn M, Farrar J (2010) Pain syndromes in cancer survivors. In: Bruera E (ed) Cancer pain: assessment and management. Cambridge University Press, New York, pp 145–162 Polomano R, Ashburn M, Farrar J (2010) Pain syndromes in cancer survivors. In: Bruera E (ed) Cancer pain: assessment and management. Cambridge University Press, New York, pp 145–162
35.
go back to reference Neligan PC, Masia J, Piller NB (2016) Lymphedema: complete medical and surgical management. Georg Thieme Verlag, StuttgartCrossRef Neligan PC, Masia J, Piller NB (2016) Lymphedema: complete medical and surgical management. Georg Thieme Verlag, StuttgartCrossRef
41.
go back to reference Deng G, Giralt S, Chung DJ, Landau H, Siman J, Search B, Coleton M, Vertosick E, Shapiro N, Chien C, Wang XS, Cassileth B, Mao JJ (2018) Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. Support Care Cancer 26(2):657–665. https://doi.org/10.1007/s00520-017-3881-7CrossRefPubMed Deng G, Giralt S, Chung DJ, Landau H, Siman J, Search B, Coleton M, Vertosick E, Shapiro N, Chien C, Wang XS, Cassileth B, Mao JJ (2018) Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. Support Care Cancer 26(2):657–665. https://​doi.​org/​10.​1007/​s00520-017-3881-7CrossRefPubMed
47.
Metadata
Title
Acupuncture in cancer care: recommendations for safe practice (peer-reviewed expert opinion)
Authors
Beverley de Valois
Teresa Young
Catherine Zollman
Ian Appleyard
Eran Ben-Arye
Mike Cummings
Ruth Green
Caroline Hoffman
Judith Lacey
Felicity Moir
Rachel Peckham
Jacqui Stringer
Susan Veleber
Matthew Weitzman
Kathrin Wode
Publication date
01-04-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08386-6

Other articles of this Issue 4/2024

Supportive Care in Cancer 4/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine